Which region accounts for the largest share in the global CAR-T Cell Therapy market ?
North America accounts for the largest share of the global CAR-T Cell Therapy market.
Who are the key players in CAR-T Cell Therapy Market ?
Major players are Novartis AG, Juno Therapeutics Inc, Kite Pharma Inc, bluebird bio, Bellicum Pharmaceuticals Inc, Immune Therapeutics Inc, Cellectis, Sorrento Therapeutics Inc, CARsgen Therapeutics Ltd and Pfizer Inc.
What is the Projected CAGR value of the CAR-T Cell Therapy Market ?
Global CAR-T Cell Therapy Market is expected to grow at a CAGR of 9.1% during the forecast period 2024-2031.